Tag: liquid embolic
First-in-human study demonstrates complete vascular occlusion with peripheral liquid embolic agent
“Our conclusion is: Amber is safe, efficacious and might change the way we technically embolise some of our indications today,” were the closing remarks...
EMBO-02 study indicates rapid cSDH resorption and pain-free treatments with NeoCast...
Arsenal Medical has announced late-breaking data from the EMBO-02 clinical study evaluating NeoCast—a next-generation, shear-responsive liquid embolic agent—in the treatment of patients with chronic...
Education and experience are needed to back ‘fascination’ with liquid embolics,...
“For me, it was essentially love at first sight,” confessed Gary Siskin (Albany Medical Center, Albany, USA), stating his enthusiasm for liquid embolics—an enthusiasm...
Guerbet receives FDA Breakthrough Device designation for Lipiojoint liquid embolic
Guerbet has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device designation to Lipiojoint, the company's transient liquid embolic agent...
iVascular initiates Opal study with new embolic liquid
iVascular has announced the initiation of Opal, the first-in-human study with the new embolic liquid Amber, based on a radiopaque biocompatible copolymer. Opal is...
Novel liquid embolic agent meets primary feasibility and safety endpoints in...
Arsenal Medical has announced that NeoCast—a first-of-its-kind, shear-responsive liquid embolic material designed for deep distal penetration—met its primary feasibility and safety endpoints in the...
Interventional News’ top 10 most popular items of September 2022
Interventional News’ most popular content last month included news of the acquisition of a new catheter by Bentley, the announcement of the final patient...
Instylla first-in-human clinical trial published results demonstrate success
A prospective multicentre study has evaluated the safety and efficacy of a polyethylene glycol (PEG)-based liquid embolic in treating hypervascular tumours, according to an...
Balt announces receiving CE mark for Magic Glue, a next generation...
Balt International has announced receiving the CE mark for Magic Glue, its next generation of cyanoacrylate liquid embolic agent. Magic Glue is indicated for...
Flowing on the horizon: Liquid embolics in development
To become a mainstay liquid embolic for peripheral use, an optimal product should be easy to use, have reproducible and controllable deep penetration for...
